Medpharm Inc.
Macheche Doing business as Procara
- UEI
- DLM6VHZ3VUN3
- CAGE
- 602B5
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 138 Kayen Chando, Macheche, 96929, Guam
- Website
- medpharmusa.net
- Founded
- 1997
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 50 Wholesale Trade – Durable Goods
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $656,867 |
| FY2025 | $894,802 |
| FY2024 | $944,482 |
| FY2023 | $746,728 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $656,867 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| V2X Systems LLC | W52P1J19F0398 | $41,725 | |
| V2X Systems LLC | W52P1J19F0398 | $37,500 |
Similar vendors
About the company
Medpharm, Inc. Division, doing business as Procara, is a minority-owned, small disadvantaged business and Asian-Pacific American-owned enterprise based in Yigo, Guam, that specializes in providing critical medical laboratory equipment, supplies, reagents, and maintenance services to federal military medical facilities. Registered in SAM.gov since May 11, 2010, Procara has established itself as a key supplier to the Department of Defense, with a demonstrated history of supporting U.S. military healthcare operations throughout the Pacific region. The company focuses on delivering sophisticated diagnostic equipment leases, consumable supplies, and comprehensive maintenance services that sustain operational readiness of military medical infrastructure, particularly at the U.S. Naval Hospital Guam.
Procara's federal contract portfolio reflects a diverse range of medical laboratory solutions provided primarily through the Defense Health Agency and the Department of the Navy's Bureau of Medicine and Surgery. The company has delivered equipment leases including BacT/Alert Virtuo Blood Culture Systems, Stago Compact MAX3 coagulation analyzers, Biomerieux Vitek 2 Compact Analyzers, Sysmex XN-2000 hematology analyzers, and various diagnostic systems, with contract values ranging from under $10,000 to over $1.4 million. Procara supplies extensive consumable materials such as blood culture bottles, coagulation reagents, microbiology media and supplies, BioFire FilmArray test panels, Abbott i-STAT cartridges, fetal fibronectin cassettes, COVID-19 test controls, and various laboratory reagents and controls. The company's service offerings include 24/7 technical support, on-site field engineer support with emergency response times of 2-4 hours, preventative maintenance, software and firmware upgrades, and training services. Recent significant awards include a $1.46 million contract for coagulation equipment and reagents (total small business set-aside, December 2024), a $994,438 award for multi-microbiology supplies (total small business set-aside, September 2024), and a $715,153 contract for blood culture system leases with maintenance (full and open competition, October 2025). Procara has also received sub-contract awards through prime contractor Vectrus Systems LLC as of August and November 2024. The company's contract awards have been issued through both set-aside designations—including total small business set-asides on approximately 40 percent of its contracts—and through full and open competition, reflecting its competitive capability in the medical supply sector serving federal military healthcare operations.
Quick answers
Is Medpharm Inc. registered in SAM.gov?
Yes. Medpharm Inc.'s SAM.gov registration is active through February 28, 2027.
How much has Medpharm Inc. received in federal contracts?
Federal contracts obligated $894,802 to Medpharm Inc. in fiscal year 2025 and $3,242,880 in fiscal years 2023 through 2027.
How does Medpharm Inc. rank among federal contractors?
Medpharm Inc. ranked #16 in PSC 6632, #32 in NAICS 325413 and #37 in PSC 6550 in FY2025.
What is Medpharm Inc.'s most recent federal award?
Medpharm Inc.'s most recent federal contract award is Lease of bact/alert virtuo blood culture system with reagents and maintenance service (HT941025PE065), from Defense Health Agency, on October 1, 2025.
On GovTribe
See Medpharm Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors